Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2014 May;12(5):821-7.
doi: 10.1016/j.cgh.2013.10.011. Epub 2013 Oct 23.

Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases

Affiliations
Multicenter Study

Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases

Ashwin N Ananthakrishnan et al. Clin Gastroenterol Hepatol. 2014 May.

Abstract

Background & aims: Vitamin D deficiency is common among patients with inflammatory bowel diseases (IBD) (Crohn's disease or ulcerative colitis). The effects of low plasma 25-hydroxy vitamin D (25[OH]D) on outcomes other than bone health are understudied in patients with IBD. We examined the association between plasma level of 25(OH)D and risk of cancers in patients with IBD.

Methods: From a multi-institutional cohort of patients with IBD, we identified those with at least 1 measurement of plasma 25(OH)D. The primary outcome was development of any cancer. We examined the association between plasma 25(OH)D and risk of specific subtypes of cancer, adjusting for potential confounders in a multivariate regression model.

Results: We analyzed data from 2809 patients with IBD and a median plasma level of 25(OH)D of 26 ng/mL. Nearly one-third had deficient levels of vitamin D (<20 ng/mL). During a median follow-up period of 11 years, 196 patients (7%) developed cancer, excluding nonmelanoma skin cancer (41 cases of colorectal cancer). Patients with vitamin D deficiency had an increased risk of cancer (adjusted odds ratio, 1.82; 95% confidence interval, 1.25-2.65) compared with those with sufficient levels. Each 1-ng/mL increase in plasma 25(OH)D was associated with an 8% reduction in risk of colorectal cancer (odds ratio, 0.92; 95% confidence interval, 0.88-0.96). A weaker inverse association was also identified for lung cancer.

Conclusions: In a large multi-institutional IBD cohort, a low plasma level of 25(OH)D was associated with an increased risk of cancer, especially colorectal cancer.

Keywords: Colorectal Cancer; Crohn’s Disease; Malignancy; Ulcerative Colitis; Vitamin D.

PubMed Disclaimer

Conflict of interest statement

Financial conflicts of interest: None

Figures

Figure 1
Figure 1
Plasma 25-hydroxy vitamin D [25(OH)D] levels in patients, stratified by subsequent diagnosis of cancer
Figure 2
Figure 2
Plasma 25-hydroxy vitamin D [25(OH)D] levels in patients, stratified by subsequent diagnosis of colorectal cancer

Comment in

References

    1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281. - PubMed
    1. Rosen CJ. Clinical practice. Vitamin D insufficiency. N Engl J Med. 2011;364:248–254. - PubMed
    1. Wacker M, Holick MF. Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation. Nutrients. 2013;5:111–148. - PMC - PubMed
    1. Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25- dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004;80:1717S–1720S. - PubMed
    1. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80:1678S–1688S. - PubMed

Publication types